Ciclesonide nasal aerosol 37 mcg

DRUG2 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

PARPerennial Allergic RhinitisSeasonal Allergic Rhinitis

Phase 3

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

CompletedNCT01451541

Sumitomo Pharma America, Inc.PAR, Perennial Allergic Rhinitis

Start: 2011-10-31End: 2012-12-31Updated: 2014-05-06

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

CompletedNCT01458275

Sumitomo Pharma America, Inc.Seasonal Allergic Rhinitis

Start: 2011-11-30End: 2013-03-31Updated: 2014-05-15